Table 2.

Measurements of parameters for determining efficacy of ExT.

Parameters	n	WKY-Sed	WKY-ExT	SHR-Sed	SHR-ExT
Body weight (BW, g)	15	320 ± 5	292 ± 4∗	305 ± 5	280 ± 4†
SMW (mg)	15	110 ± 3	136 ± 4∗	105 ± 5	137 ± 4†
SMW/BW (mg/g)	15	0.34 ± 0.01	0.47 ± 0.01∗	0.34 ± 0.01	0.49 ± 0.01†
CS in SMW (pg/mg)	15	672 ± 25	790 ± 35∗	685 ± 25	778 ± 30†
MAP (mmHg)	10	122 ± 3	116 ± 6	175 ± 5∗	150 ± 5∗†
HR (beats/min)	10	397 ± 8	352 ± 9∗	453 ± 8∗	392 ± 7†
NE in 24 h urine (μg)	10	0.41 ± 0.03	0.39 ± 0.05	0.71 ± 0.05∗	0.55 ± 0.04∗†

n: number of animals; MAP: mean arterial pressure; SMW: soleus muscle wet weight; CS: citrate synthase; MAP: mean arterial pressure; NE: norepinephrine; WKY-Sed: Wistar-Kyoto-sedentary; SHR-Sed: spontaneously hypertensive rat-sedentary; WKY-ExT: Wistar-Kyoto-exercise training; SHR-ExT: spontaneously hypertensive rat-exercise training. Data are mean ± SE. Values for MAP and HR were obtained in anaesthetized rats. MAP was measured by catheterizing femoral artery. ^∗ P < 0.05 versus WKY-Sed. ^† P < 0.05 versus SHR-Sed.